STOCK TITAN

Insulet (NASDAQ: PODD) director reports sale of 1,851 common shares at $293.09

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

A director of Insulet Corp (PODD) sold 1,851 shares of common stock on 12/15/2025. The transaction is coded "S," indicating a sale of non-derivative securities.

The reported sale price was $293.09 per share. After this transaction, the reporting person beneficially owns 2,158 shares of Insulet common stock, held in direct ownership form.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Frederick Wayne A.I.

(Last) (First) (Middle)
C/O INSULET CORPORATION
100 NAGOG PARK

(Street)
ACTON MA 01720

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/15/2025 S 1,851 D $293.09 2,158 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Patricia K. Dolan, attorney-in-fact 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Insulet (PODD) disclose in this filing?

The filing reports that a director of Insulet Corp sold 1,851 shares of common stock in a transaction coded "S" on 12/15/2025.

At what price were the Insulet (PODD) shares sold in this insider transaction?

The 1,851 Insulet common shares were reported sold at a price of $293.09 per share.

How many Insulet (PODD) shares does the insider own after this sale?

Following the reported transaction, the reporting person beneficially owns 2,158 shares of Insulet common stock in direct ownership form.

When did the reported Insulet (PODD) stock sale take place?

The insider stock sale occurred on 12/15/2025, as shown in the transaction date field of the filing.

What is the relationship of the reporting person to Insulet (PODD)?

The reporting person is identified as a Director of Insulet Corp, as indicated in the relationship section of the form.

Does this Insulet (PODD) filing involve any derivative securities?

No derivative securities are listed with transactions in Table II; only a sale of common stock appears in Table I.

Insulet Corp

NASDAQ:PODD

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

20.37B
70.13M
0.27%
101.79%
2.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON